Muscle relaxants used in Cluster Headache management primarily target central nervous system pathways to reduce muscle tension and neurogenic inflammation. By acting on GABA receptors or blocking neuromuscular transmission, these agents decrease muscle spasticity and can potentially modulate pain perception, offering symptomatic relief in the complex pathophysiology of Cluster Headache.